Shares of Extendicare Inc. (TSE:EXE – Get Free Report) have been assigned a consensus recommendation of “Buy” from the seven research firms that are covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 1 year target price among analysts that have covered the stock in the last year is C$37.06.
Several equities research analysts recently issued reports on the company. National Bank Financial decreased their price target on Extendicare from C$45.00 to C$40.00 and set an “outperform” rating for the company in a report on Wednesday, October 21st. Royal Bank Of Canada raised their price objective on Extendicare from C$38.00 to C$39.00 and gave the company an “outperform” rating in a research note on Friday, August 14th. Canaccord Genuity Group raised their price objective on Extendicare from C$37.00 to C$44.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Finally, Desjardins lifted their price objective on shares of Extendicare from C$39.00 to C$39.50 and gave the stock a “buy” rating in a report on Monday, November 9th.
Read Our Latest Stock Report on EXE
Extendicare Stock Up 0.8%
EXE traded up C$0.25 during midday trading on Friday, reaching C$30.34. 476,093 shares of the company were exchanged, compared to its average volume of 448,726. The company has a debt-to-equity ratio of 137.74, a quick ratio of 0.98 and a current ratio of 0.68. The company’s fifty day moving average price is C$28.83 and its 200 day moving average price is C$30.19. The company has a market cap of C$2.88 billion, a price-to-earnings ratio of 22.03 and a beta of 1.31. Extendicare has a one year low of C$18.81 and a one year high of C$39.14.
Extendicare (TSE:EXE – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported C$0.41 earnings per share for the quarter. The company had revenue of C$627.84 million for the quarter. Extendicare had a return on equity of 32.84% and a net margin of 6.06%. As a group, analysts expect that Extendicare will post 0.61 EPS for the current year.
Extendicare Dividend Announcement
The company also recently declared a monthly dividend, which will be paid on Monday, November 16th. Investors of record on Monday, November 16th will be given a dividend of $0.0441 per share. This represents a $0.53 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, October 30th. Extendicare’s dividend payout ratio (DPR) is presently 37.67%.
Extendicare Company Profile
Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.
Further Reading
- Five stocks we like better than Extendicare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
